Greensignal Bio Pharma Profile
Key Indicators
- Authorised Capital ₹ 315.00 Cr
as on 10-12-2024
- Paid Up Capital ₹ 294.26 Cr
as on 10-12-2024
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.89 Cr
as on 10-12-2024
- Satisfied Charges ₹ 24.15 Cr
as on 10-12-2024
- Revenue -51.29%
(FY 2022)
- Profit -382.30%
(FY 2022)
- Ebitda -209.78%
(FY 2022)
- Net Worth 39.67%
(FY 2022)
- Total Assets 31.95%
(FY 2022)
About Greensignal Bio Pharma
The Corporate was formerly known as Greensignal Bio Pharma Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 315.00 Cr and a paid-up capital of Rs 294.26 Cr.
The company currently has active open charges totaling ₹5.89 Cr. The company has closed loans amounting to ₹24.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Greensignal Bio Pharma Private Limited India is Satyajit Dash as COMPANY SECRETARY. Murali Pakshirajan and Chandrasekaran Sorubanandam serve as directors at the Company.
- CIN/LLPIN
U24232TN2005PTC058068
- Company No.
058068
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 2005
- Date of AGM
05 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Greensignal Bio Pharma Private Limited offer?
Greensignal Bio Pharma Private Limited offers a wide range of products and services, including Immunization & Vaccination Drugs, Vaccines, BCG Vaccine.
Who are the key members and board of directors at Greensignal Bio Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murali Pakshirajan  | Managing Director | 06-Oct-2008 | Current |
| Satyajit Dash | Company Secretary | 20-Jun-2019 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandrasekaran Sorubanandam | Whole-Time Director | 06-Oct-2008 | Current |
Financial Performance of Greensignal Bio Pharma.
Greensignal Bio Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 51.29% decrease. The company also saw a substantial fall in profitability, with a 382.3% decrease in profit. The company's net worth Soared by an impressive increase of 39.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Greensignal Bio Pharma?
In 2022, Greensignal Bio Pharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 20 Sep 2024 | ₹2.37 M | Open |
Indian Overseas Bank Creation Date: 16 May 2024 | ₹5.62 M | Open |
Indian Overseas Bank Creation Date: 16 May 2024 | ₹4.72 M | Open |
How Many Employees Work at Greensignal Bio Pharma?
Greensignal Bio Pharma has a workforce of 117 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Greensignal Bio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Greensignal Bio Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
